Study Shows Experimental Ebola Vaccine Appears Promising; Large Trial Begins In West Africa
The Atlantic: Ebola Vaccine Appears Safe, Effective
“Tests of an experimental Ebola vaccine have found that 100 percent of vaccinated people mounted a promising immune response and incurred no serious side effects, according to results published [Thursday] morning in The New England Journal of Medicine…” (Hamblin, 4/2).
Daily Mirror: ‘Successful’ Ebola vaccine administered in crisis countries Guinea, Sierra Leone and Liberia
“An Ebola jab is being given to people living in the West African areas hit most by the virus after human trials in unaffected countries proved successful. Scientists hope immunization is possible with just one injection after ‘highly promising results’ in the first 138 healthy adults who were vaccinated with various doses…” (4/2).
Wired: Ebola vaccine reaches West Africa for massive human trial
“A 27,000-person trial of an Ebola vaccine tested by a London university has started in West Africa. The number of volunteers involved in the trial just tops the number of people that have been infected with the vicious disease since the outbreak began – a harrowing 25,178…” (Clark, 4/2).